Park Dental Partners Inc

Aktienanalyse zu Park Dental Partners Inc (PARK)

$20.850

-0.890 (-4.27%)Zum Schluss

Loading chart…
High
21.660
Open
21.095
VWAP
20.90
Vol
13.60K
Mkt Cap
Low
20.200
Amount
284.35K
EV/EBITDA, TTM
-5.11

Park Dental Partners, Inc. is a dental resource organization. The Company provides business support services including clinical team members, administrative personnel, facilities and equipment to its affiliated general and multi-specialty dental practices (which are not legal subsidiaries) throughout Minnesota and Wisconsin. Its network of affiliated dental practices provides both general and specialty dental services, including oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics. Its brands include Park Dental, Apollo Dental Center, Greenview Cosmetic & Family Dentistry, The Facial Pain Center, The Dental Specialists (TDS), The Dental Specialists (TDS) Orthodontics, and Central Minnesota Endodontics. Its Greenview Cosmetic & Family Dentistry provides a range of oral health and cosmetic services to patients. Central Minnesota Endodontics offers patients endodontic care using surgical techniques and technologies.

AI analysis of Park Dental Partners Inc (PARK)

buy

Park Dental Partners, Inc. is a good buy right now due to its recent earnings performance and growth trajectory. The stock is currently priced at $20.85, with a significant 1-year change of +60.38%. The forward P/E ratio is 0, indicating potential undervaluation. Additionally, the company reported a Q1 2026 non-GAAP EPS of $0.44, exceeding expectations by $0.24, which reflects strong profitability despite some challenges. However, the main risk is the high debt-to-equity ratio of 37.00%, which could impact financial stability if not managed properly.

Bewertungskennzahlen

The current forward P/E ratio for Park Dental Partners Inc (PARK) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Überbewertet
0.00
Unterbewertet
0.00

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
-1.23
Current EV/EBITDA
-5.11
Überbewertet
0.90
Unterbewertet
-3.35

Forward P/S

Fair
5Y Average P/S
0.26
Current P/S
0.35
Überbewertet
0.36
Unterbewertet
0.16

Event-Zeitleiste

2026-08-12 (ET)

17:30:00

Company Updates FY26 Outlook, Adjusts EBITDA to $21M-$23M

17:30:00

Company Reports Q2 Revenue of $66.21M

2026-08-10 (ET)

08:30:00

Park Dental Partners Acquires Village Family Dental DSO

2026-02-25 (ET)

17:00:00

Company Reports Q4 Revenue of $61.2M, Up from $56.9M Last Year

17:00:00

Company Outlook Includes 3.5%-5.0% Same Practice Revenue Growth

News

PARK FAQ — answered by Alphio AI

Park Dental Partners, Inc. is a dental resource organization. The Company provides business support services including clinical team members, administrative personnel, facilities and equipment to its affiliated general and multi-specialty dental practices (which are not legal subsidiaries) throughout Minnesota and Wisconsin. Its network of affiliated dental practices provides both general and specialty dental services, including oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics. Its brands include Park Dental, Apollo Dental Center, Greenview Cosmetic & Family Dentistry, The Facial Pain Center, The Dental Specialists (TDS), The Dental Specialists (TDS) Orthodontics, and Central Minnesota Endodontics. Its Greenview Cosmetic & Family Dentistry provides a range of oral health and cosmetic services to patients. Central Minnesota Endodontics offers patients endodontic care using surgical techniques and technologies. It operates in the Healthcare sector.

Park Dental Partners, Inc. is a good buy right now due to its recent earnings performance and growth trajectory. The stock is currently priced at $20.85, with a significant 1-year change of +60.38%. The forward P/E ratio is 0, indicating potential undervaluation. Additionally, the company reported a Q1 2026 non-GAAP EPS of $0.44, exceeding expectations by $0.24, which reflects strong profitability despite some challenges. However, the main risk is the high debt-to-equity ratio of 37.00%, which could impact financial stability if not managed properly.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten